ArticleBMC cancer2022

Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.

Yiqiao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.